Goldman Sachs Group Inc Third Harmonic Bio, Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 69,410 shares of THRD stock, worth $885,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,410
Previous 36,312
91.15%
Holding current value
$885,671
Previous $472,000
99.15%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding THRD
# of Institutions
83Shares Held
43.6MCall Options Held
7.1KPut Options Held
0-
Atlas Venture Life Science Advisors, LLC10.9MShares$139 Million18.24% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$73.7 Million1.85% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$55.7 Million1.88% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.18MShares$40.6 Million1.87% of portfolio
-
General Atlantic LLC New York, NY2.96MShares$37.8 Million1.15% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $515M